KCNAB2

Across TCGA pan-cancer cohorts, KCNAB2 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated KCNAB2 data layer compared with 24 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher KCNAB2 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated KCNAB2 expression acts as an unfavorable survival marker.

COAD, CCRCC, and PDAC are the cancer types where KCNAB2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	II,III,IV	0.910	1.000	.011	66	view →
CCRCC	OS	Quartile	All	0.583	1.000	.012	5	view →
PDAC	DFS	Tertile	II,III,IV	0.609	0.886	.015	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

KCNAB2–COAD (DFS)

Open the COAD breakdown →